Eyenovia
Price & Volume
Stats
See more52W Range | $1.20-$124.80 |
Market Cap | $2.6M |
Shares Short | 249,414 |
Financials
See moreRevenue (12 Mos) | $31,832 |
Revenue Growth (YoY) | 35.6% |
Gross Profit (12 Mos) | -$5.6M |
Diluted EPS | -$55.20 |
News
See moreYahoo Finance • 8 days ago
Eyenovia Enters into Non-Binding Letter of Intent to Effect Reverse Merger with Betaliq
Yahoo Finance • last month
Eyenovia, Inc. Announces Debt Restructuring Including Amendment to Senior Secured Debt, Improving Cash Runway to Allow for the Evaluation of Strategic Alternatives
Yahoo Finance • 2 months ago
Eyenovia Announces Progress on Next-Generation User-Filled Optejet Dispensing Device
Yahoo Finance • 2 months ago
Eyenovia Announces 1-for-80 Reverse Stock Split
About
CEO | Mr. Michael M. Rowe |
Address | 295 Madison Avenue, New York, NY, United States, 10017 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 57 |
